Public subsidies for R&D and public sector pharmaceutical innovation
Year of publication: |
2021
|
---|---|
Authors: | Kourouklis, Dimitrios |
Published in: |
Applied economics. - New York, NY : Routledge, ISSN 1466-4283, ZDB-ID 1473581-7. - Vol. 53.2021, 32, p. 3759-3777
|
Subject: | Drug Development | pharmaceutical Innovation | public Sector | public Subsidies | research & Development | Öffentlicher Sektor | Public sector | Subvention | Subsidy | Pharmaindustrie | Pharmaceutical industry | Forschungsfinanzierung | Research funding | Innovation | Arzneimittel | Pharmaceuticals | Pharmakologie | Pharmacology | Industrieforschung | Industrial research | Technologiepolitik | Technology policy | Wirkungsanalyse | Impact assessment |
-
R&D grants and medical innovation
Unsal, Omer, (2024)
-
Byrski, Dennis, (2021)
-
Health policy, price regulation, and innovation : evidence from China's vaccine industry
Geng, Hao, (2024)
- More ...
-
Revisiting the Relationship Between Price Regulation and Pharmaceutical R&D Investment
Shaikh, Mujaheed, (2020)
-
Pharmaceutical spending and early-stage innovation in EU countries
Kourouklis, Dimitrios, (2022)
-
Kourouklis, Dimitrios, (2023)
- More ...